Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4799 USD | +4.10% | +4.10% | -60.01% |
Apr. 02 | Centogene Gets Nasdaq Noncompliance Notice | MT |
Mar. 19 | Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics | MT |
Sales 2023 * | 48.62M 52.19M | Sales 2024 * | 59.5M 63.87M | Capitalization | 12.48M 13.4M |
---|---|---|---|---|---|
Net income 2023 * | -48M -51.52M | Net income 2024 * | -45M -48.3M | EV / Sales 2023 * | 0.26 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.21 x |
P/E ratio 2023 * |
-0.28
x | P/E ratio 2024 * |
-0.46
x | Employees | 444 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 69.49% |
1 day | +4.10% | ||
1 week | +4.10% | ||
Current month | -32.41% | ||
1 month | -33.21% | ||
3 months | -58.98% | ||
6 months | -53.86% | ||
Current year | -60.01% |
Managers | Title | Age | Since |
---|---|---|---|
Kim Stratton
CEO | Chief Executive Officer | 62 | 21-12-19 |
Director of Finance/CFO | - | 22-02-07 | |
Chief Tech/Sci/R&D Officer | 64 | 21-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peer Schatz
CHM | Chairman | 57 | 20-03-15 |
Hubert Birner
BRD | Director/Board Member | 57 | 17-06-30 |
Flemming Ørnskov
BRD | Director/Board Member | 66 | 19-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.4799 | +4.10% | 7,168 |
24-04-24 | 0.461 | -3.96% | 19,900 |
24-04-23 | 0.48 | +2.11% | 71,989 |
24-04-22 | 0.4701 | +3.11% | 434,353 |
24-04-19 | 0.4559 | -1.11% | 79,406 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.01% | 13.37M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- CNTG Stock